Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Accenture
Argus Health
US Department of Justice
McKesson
Teva
Chubb
McKinsey
Covington

Generated: October 22, 2018

DrugPatentWatch Database Preview

ALFENTA Drug Profile

« Back to Dashboard

When do Alfenta patents expire, and what generic alternatives are available?

Alfenta is a drug marketed by Akorn and Hospira and is included in two NDAs.

The generic ingredient in ALFENTA is alfentanil hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.

Drug patent expirations by year for ALFENTA
Pharmacology for ALFENTA
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for ALFENTA
Synonyms for ALFENTA
333JTI7A2M
69049-06-5
71124-01-1
AC1L21VB
AKOS015966535
Alfentanil HCl
Alfentanil hydrochloride
Alfentanil hydrochloride [USAN]
Alfentanil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
ALFENTANILHYDROCHLORIDE
Alfentanyl Hydrochloride
Ambap69049-06-5
AQORHZJDCHLLJN-UHFFFAOYSA-N
C-22518
CAS-69049-06-5
CHEMBL1200531
D0A3ES
DSSTox_CID_28853
DSSTox_GSID_48927
DSSTox_RID_83122
DTXSID0048927
EINECS 273-846-3
Fentalim
FT-0630781
LS-119260
MLS002320667
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)piperidin-4-yl)-N-phenylpropionamide hydrochloride
N-[1-[2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenyl-propanamide Hydrochloride
N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide hydrochloride
NCGC00247354-02
OX-51
Propanamide, N-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)-4-piperidinyl)-N-phenyl-, monohydrochloride
R 39209
Rapifen
SCHEMBL40459
SMR001338813
Tox21_112878
UNII-333JTI7A2M

US Patents and Regulatory Information for ALFENTA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn ALFENTA alfentanil hydrochloride INJECTABLE;INJECTION 019353-001 Dec 29, 1986 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ALFENTANIL alfentanil hydrochloride INJECTABLE;INJECTION 075221-001 Oct 28, 1999 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Accenture
Argus Health
US Department of Justice
McKesson
Teva
Chubb
McKinsey
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.